scanance.
Sign inGet Premium
OP

OppFi Inc.

OPFIFinancial ServicesNASDAQ

Credit Services · Last scanned Jun 3, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$597.0M
+13.5% YoY
Net Income
$26.3M
+262.8% YoY
EBITDA
$387.7M
+25.6% YoY

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About OppFi Inc.

Headquartered within the financial services sector, OppFi Inc. focuses on Credit Services services and products. OppFi Inc., a tech-enabled digital finance platform, provides financial products and services for banks in the United States. With a market capitalization of $1.20B, it sits in small-cap territory. The company offers installment loans through OppLoans platform.

Key stats
Market Cap$1.20B
P/E (TTM)4.12
Fwd P/E3.91
EPS$2.03
Beta1.87
52W Change-38.0%
ROE62.1%
Analysis

OppFi Inc. carries $295.2M in total debt against $63.9M in cash reserves — debt is roughly 4.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. Return on equity stands at 62.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 26.5% further supports the picture of efficient asset utilization. Revenue has grown from $452.9M (2022) to $597.0M (2025), reflecting a 32% increase over the period.

A beta of 1.87 means OPFI is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence OppFi Inc.'s trajectory.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms